There is a lack of consensus among investigators who use a variety of immunoassay techniques (e.g., enzyme-linked immunosorbent assay [ELISA] and radioimmunoassay) regarding the protocols for describing and forming standard reference or calibration curves and interpolating serum antibody concentrations. This confounds the issue of detecting the presence or absence of parallelism between standard reference serum and serially diluted serum sample curves. These curves must be parallel to support the assumption that the antibody-binding characteristics are similar enough to allow the determination of antibody levels in the diluted serum sample. There is no universal and widely adopted strategy for assessing parallelism in bioassays, and without an assurance of parallelism, There is a lack of consensus among investigators who use a variety of immunoassay techniques (e.g., enzyme-linked immunosorbent assay [ELISA] and radioimmunoassay) regarding the protocols for describing and forming standard reference or calibration curves and interpolating serum antibody concentrations. A wide variety of curve-fitting methods are used to generate standard reference or calibration curves. Rodgers (18) listed many of these methods in a report that included an extensive bibliography. The most common functional models for calibration curves range from the simple linear log-log and logit-log transformations to the more complex four-parameter nonlinear logistic-log models (14). These models also include a range of spline functions (7, 8 The most common test for parallelism is an analysis of variance (ANOVA) technique applied to sets of straight-line data (2, 5) . This technique presupposes that the standard reference and serum sample curves are linear and will work with the log-log, logit-log, and any other linearizing transformation. More complicated ANOVA procedures test for the equivalence of one or more parameters in nonlinear functions, such as the four-parameter logistic-log model (15). These tests may be used to examine one parameter which simply describes the similarity between slopes of one or more curves or several parameters that, when taken together, describe the similarity of the overall shape of the nonlinear curves (7, 8, 15 
standard reference serum and serially diluted serum sample curves are fit with little error, standard analysis of variance techniques are overly sensitive to negligible departures from parallelism. We present a series of guidelines that compose a protocol for assessing parallelism between bioassay dilution curves that are applicable to data derived from ELISAs. These criteria should be applicable, with minor modifications, to most immunoassay experimental situations and, most importantly, are not dependent on the mathematical model used to form the standard reference curve. These guidelines have evolved in our laboratories over the past 4 years during the performance of thousands of ELISAs for antibodies to the capsular polysaccharides of Neisseria meningitidis groups A and C and Haemophilus influenzae type b.
There is a lack of consensus among investigators who use a variety of immunoassay techniques (e.g., enzyme-linked immunosorbent assay [ELISA] and radioimmunoassay) regarding the protocols for describing and forming standard reference or calibration curves and interpolating serum antibody concentrations. A wide variety of curve-fitting methods are used to generate standard reference or calibration curves. Rodgers (18) listed many of these methods in a report that included an extensive bibliography. The most common functional models for calibration curves range from the simple linear log-log and logit-log transformations to the more complex four-parameter nonlinear logistic-log models (14) . These models also include a range of spline functions (7, 8) . The proliferation of existing methods for standard reference curve formation clearly indicates that no one descriptive model will work optimally for all experimental situations and assays. Each model possesses advantages and disadvantages and must be judged on its applicability to the experiment at hand.
These concerns confound the issue of detecting the presence or absence of parallelism between standard reference serum and serially diluted serum sample curves. These curves must be parallel to support the assumption that the antibody-binding characteristics are similar enough to allow the determination of antibody levels in the diluted serum sample. No universal strategy for assessing parallelism in bioassays has been widely adopted, and without an assurance of parallelism, investigators are not able to calculate reliable estimates for serum antibody concentrations. Furthermore, single-point (dilution) serum assays do not provide information related to parallelism and nonparallelism, and this, too, may lead to considerable error when calculating antibody concentrations.
The most common test for parallelism is an analysis of variance (ANOVA) technique applied to sets of straight-line data (2, 5) . This technique presupposes that the standard reference and serum sample curves are linear and will work with the log-log, logit-log, and any other linearizing transformation. More complicated ANOVA procedures test for the equivalence of one or more parameters in nonlinear functions, such as the four-parameter logistic-log model (15) . These tests may be used to examine one parameter which simply describes the similarity between slopes of one or more curves or several parameters that, when taken together, describe the similarity of the overall shape of the nonlinear curves (7, 8, 15 (14) .
(iii) Partially specified logit-log model. A reduced form of the fully specified logit-log model may be derived by assuming that the OD associated with a zero concentration should be 0.
This would lead to the ODmi parameter of the fully specified logit transformation being set equal to 0 (14) . The resulting partially specified (ps) logit transformation is defined as: GOD Logit (OD)ps = log GODma-OD (3) (iv) Statistical analysis. The data in the present study were displayed on fully or partially specified logit-log scales by using a relative dilution series to facilitate visual comparisons between the standard reference serum and the serum sample curves. Frequently, the initial dilution of a serum sample will differ from that of the standard reference serum sample. Dividing each dilution in a series by the maximum dilution of that series will always place the standard reference serum sample and the serum sample dilution sequences on the same relative dilution scale:
Relative dilutioni = actual sample dilutioni *100 maximum dilution in series (4) Each regression line was fit by standard weighted regression techniques to account for the heteroscedasticity (uneven variances) in the data by the SAS REG procedure (19) . The lower and upper asymptotes of the logistic-log curves describing these data sets were used for the ODmin and ODma, parameters in the logit calculations and were estimated by using the ELISA software package developed at the Centers for Disease Control and Prevention (13) . For comparison purposes standard ANOVAs for parallelism between straight-line curves were made by using the SAS GLM procedure (one-way analysis of covariance) (19) . All computations were made by using a Compaq Deskpro 386s/20 personal computer equipped with a math coprocessor (Compaq Computer Corporation, Houston, Tex.). Figure 1 displays the results of two typical ELISAs for H. influenzae type b with the standard reference serum sample (FDA 1983) and two serially diluted serum samples. These data are used to illustrate the calculations necessary to interpolate antibody concentrations for a serially diluted serum sample when both the standard reference serum (standard) and the serum sample bioassay curves are parallel (Fig. 1A ) and when both curves are clearly not parallel (Fig. 1B) . The datum points associated with the three lowest ODs of the serum samples in Fig. 1A had undefined fully specified logits because their ODs fell below their respective ODmin parameters (i.e., the lower asymptotes of their logistic-log curves). Although the logit-log transformation was used for this de- Fig.  1B were 2.00 and 9.25 ,ug/ml, respectively. The antibody concentration for point 2 was more than 4.5 times greater than that for point 1. For these data, the individual antibody concentrations ranged from 1.37 to 25.71 ,ug/ml; the mean antibody concentration was 6.46 p.g/ml, with a standard deviation of 6.18 ,ug/ml. The slope of the serum sample curve was less than that of the standard reference curve, and the estimated antibody concentrations steadily increased from the first point associated with the greatest OD to the last point associated with the lowest OD. If the slope of the serum sample curve were greater than that of the standard reference curve, the estimated antibody concentrations would steadily decrease from the first to the last point. These are positive indications for the lack of parallelism between standard reference serum and serum sample curves. Additional indications for nonparallelism are reflected in the large degree of variability about the mean antibody concentration and the inflated CV (95.66%). If one were to eliminate the points associated with the two most extreme dilutions because of their excessive variability, these statistics would still provide strong evidence for nonparallelism; the individual antibody concentrations would then range from 1.37 to 9.25 ,ug/ml. The revised mean would be 3.96 ,ug/ml, with a standard deviation of 2.45 ,ug/ml and a CV of 61.78%. Figure 2 displays the results of a typical ELISA for H. influenzae type b with a common standard reference serum sample (FDA 1983) and two serially diluted serum samples and is used to illustrate the difficulties in applying ANOVA techniques to screen for nonparallelism of assay slopes. The datum points associated with the three lowest ODs of both serum samples had undefined fully specified logits as their ODs fell below their respective ODmin parameters (i.e., the lower asymptotes of their logistic-log curves). The slopes for the common standard reference and serum sample curves 1 and 2 were 1.370, 1.366, and 1.263, respectively. The differences in the slopes were 0.004 in Fig. 2A and 0 .107 in Fig. 2B . Standard ANOVAs revealed that the P value associated with measuring parallelism or the equivalence of slopes between the two lines in Fig. 2A was less than 0.75, indicating that the two slopes are not significantly different. Figure 2B represents two lines with a slightly larger difference in slopes and yields a P value of <0.0005 for the test for parallelism. Although the difference in slopes for the lines in Fig. 2B Many investigators linearize sigmoid-shaped data to facilitate tests for parallelism using the log-log or logit-log transformations. In these cases, the identities of the asymptotes are lost. Figure 3 displays a series of logistic-log curves (Fig. 3A) , with their straight-line counterparts (Fig. 3B) , computed by using the fully specified logit-log transformation. In Fig. 3A Fig. 3B have identical slopes. The only differences in slopes of the logit-log lines occurred when the slopes of the respective logistic-log functions differed, as shown by curve-line 5. The positions of the asymptotes of the logistic-log curves had no effect on the presence or absence of parallelism between the logit-log lines.
RESULTS
The logit-log transformation may be calculated in at least two ways (fully and partially specified) by using a variety of choices for the ODmin and ODmax These decisions will also affect the nature of parallelism and nonparallelism in the transformed straight lines. Figure 4 displays ([l) . (A) Lines plotted on a fully specified logit-log scale; the slopes for the standard reference and serum sample curves are 1.370 and 1.366, respectively. (B) Lines plotted on a partially specified logit-log scale; the slopes for the standard reference and serum sample curves are 1.366 and 0.906, respectively. ence serum sample (FDA 1983 ) and a serially diluted serum sample plotted on fully specified (Fig. 4A ) and partially specified (Fig. 4B) logit-log scales. The datum points associated with the three lowest ODs of the serum sample had undefined fully specified logits as their ODs fell below the lower asymptote of the logistic-log curve. These points did, however, have definable partially specified logits. For this reason, these points are absent from Fig. 4A and present in Fig. 4B . The degree of parallelism and nonparallelism is strongly influenced by the method of linearizing transformation. Standard ANOVA testing revealed that the slopes of the two lines in Fig. 4A were not significantly different (P < 0.75), while the slopes in Fig. 4B were significantly different (P < 0.0005). An additional concern that arises when comparing the partially and fully specified logit models is related to the disparity in antibody concentrations derived from each transformation. The mean antibody concentration for the serum sample in Fig. 4A Fig. 4 . The logit-log transformation is one of the most popular of the linearizing transformations, and it may be calculated in several different ways, depending on the choice of the model (equation 2 or 3) and the selection of values used for ODmin and ODma,, Generally, the fully specified logit-log transformation will retain the most accurate representation of differences between slopes when maximum likelihood estimates for d and a from the logistic-log model are used for ODmin and ODmax, respectively, as in equation 2 (14) . In actual practice, these estimates will typically be unknown since it is unlikely that one would estimate standard reference and serum sample curves by more than one technique. This would force the investigator to substitute less-than-ideal values for these parameters, unduly affecting the slopes of the curves and possibly leading to incorrect conclusions regarding parallelism and nonparallelism between the straight lines.
Large discrepancies may exist between the mean antibody concentrations derived from the partially and fully specified logit transformations. Jeffcoate and Das (9) and Pegg and Miner (10) have shown that differences in data processing techniques account for a significant portion of between-assay variability. Pegg and Miner (10) also demonstrated that different implementations of the same calibration formulas (the logit-log technique) gave significantly different results. To illustrate this point, the mean antibody concentration for the serum sample in Fig. 4B (partially specified logit-log, 1.72 ,ug/ml) is more than twice that for the serum sample in Fig. 4A (fully specified logit log, 0.78 ,ug/ml). If an investigator used the partially specified logit-log transformation and was unfamiliar with the paralellism and nonparallelism issues discussed here, the reported result could be in serious error. This arbitrariness of the logit-log transformation argues for keeping the data in its untransformed state when comparing the slopes of bioassay curves and computing antibody concentrations. It also suggests that greater attention should be paid to the standardization of bioassay data processing and analysis software (18) . This is especially true for large studies in which several collaborating laboratories analyze the same collection of specimens.
Large standard deviations and CVs for mean antibody concentration calculations of serum samples may be attributable to the inadequacy of the mathematical model chosen to describe the dilution curve (14) , to excessive variation in ODs related to the serum sample, or to the presence of nonparallelism between the serum sample and the standard reference Table 1 . With minor modifications, these guidelines should be applicable in most immunoassay experimental situations. In our laboratories, we find the logistic-log model describes our data with the greatest accuracy over the widest dilution range (14) when computing antibody concentrations for serum samples. However, our proposed guidelines are not dependent on the underlying functional form used to model the standard reference curve, and as such, they may be applied more generally to a wider body of experimental situations.
These guidelines serve as a useful alternative to standard ANOVA techniques when assessing the parallelism and nonparallelism between bioassay dilution curves. When applied to the data displayed in Fig. 2 , the mean calculated H. influenzae antibody concentration for serum sample 1 ( Fig. 2A) These issues underscore the importance of performing multipoint assays for serum samples. Single-point (dilution) serum assays may be inaccurate if the assay point does not fall within the most accurate portion of the standard reference curve. If the serum assay point falls outside the range of the standards, the assay must be repeated. If the serum assay point falls near the limits of detectability for the standard reference assay, the calculated concentration for the serum sample will be associated with an inflated standard error. This may lead an investigator to question the reliability of the calculated concentration and, possibly, to repeat the assay. Also, single-point assays for serum samples may lead to serious miscalculations of concentrations in serum when certain linearizing transformations (log-log) are used for the standard reference serum curve (14) . Finally, single-point assays do not give an investigator the necessary information to determine whether an assay is parallel to the standard reference serum assay, casting doubt on the validity of the calculated concentration in the serum sample.
We believe that the issues outlined here will assist investigators in forming an objective approach for detecting parallelism and nonparallelism between standard reference serum and serum specimen bioassays. The adoption of these guidelines in protocols that include bioassay analyses can standardize the calculation of serum antibody concentrations, limiting the variability and increasing the reliability of these measurements. This will facilitate the comparison of results within and among laboratories, especially in large studies in which several collaborating laboratories analyze the same collection of specimens.
